Home/Exact Sciences/Jeffrey T. Elliott
JT

Jeffrey T. Elliott

Chief Financial Officer

Exact Sciences

Therapeutic Areas

Exact Sciences Pipeline

DrugIndicationPhase
CancerGuard™Multi-Cancer Early DetectionPivotal Studies
Oncotype DX® AR-V7 Nucleus Detect™Metastatic Castration-Resistant Prostate Cancer (mCRPC)Commercial
ctDNA MRD MonitoringColorectal Cancer (Stage II/III)Clinical Validation
Next-Generation Cologuard®Colorectal Cancer ScreeningDevelopment